What is the current size and annual growth rate of the dermatitis market?
The dermatitis market size has grown strongly in recent years. It will grow from $6.77 billion in 2024 to $7.13 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to increased prevalence, diagnostic advancements, treatment options, regulatory approvals.
The dermatitis market size is expected to see steady growth in the next few years. It will grow to $8.66 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to growing patient awareness, environmental factors. Major trends in the forecast period include research and development, telemedicine and digital health, biologics and targeted therapies, personalized medicine.
Get Your Free Sample of The Global Dermatitis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2413&type=smp
Which major factors have contributed to the expansion of the dermatitis market?
Growth in the dermatitis market is primarily driven by the increasing global prevalence of the disease. The prevalence of dermatitis in children is estimated to be around 15-20% while it is 1-3% in adults. The rising cases of food allergies are adding to the prevalence of dermatitis which ultimately leads to the increase in demand for medicines to cure this disease. For instance, in October 2022, according to the Global Atopic Dermatitis Atlas (GADA), a report published by the International Eczema Council (IEC), a US-based international dermatology association, approximately 223 million individuals were reported to be affected by atopic dermatitis in 2022. Out of this total, around 43 million were in the age group of 1 to 4 years.
How is the dermatitis market segmented?
The dermatitis market covered in this report is segmented –
1) By Drug Class: Corticosteroids, Emollients Or Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors
2) By Distribution Channel: Hospital, Retail Pharmacies, Drug Stores, Online Or Mail Pharmacies
3) By Application: Cancer, Blood Disorders, Chronic Diseases, Infectious Diseases
Subsegments:
1) By Corticosteroids: Topical Corticosteroids, Oral Corticosteroids, Injectable Corticosteroids
2) By Emollients Or Moisturizers: Creams, Ointments, Lotions, Gels, Other Emollients Or Moisturizers
3) By Antihistamines: Oral Antihistamines, Topical Antihistamines, Injectable Antihistamines
4) By Calcineurin Inhibitors: Topical Calcineurin Inhibitors (Tacrolimus, Pimecrolimus), Oral Calcineurin Inhibitors
5) By Antibiotics: Topical Antibiotics, Oral Antibiotics, Systemic Antibiotics
6) By Immunomodulators: Topical Immunomodulators, Oral Immunomodulators
7) By Interleukin Inhibitors: IL-4 Inhibitors, IL-13 Inhibitors, IL-31 Inhibitors, Other Interleukin Inhibitors
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report
Who are the top competitors in the dermatitis market?
Major companies operating in the dermatitis market include LEO Pharma AS, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Bayer AG, Encore Dermatology Inc., Meda Pharmaceuticals Inc., Allergan Plc, Bristol-Myers Squibb Co., Anacor Pharmaceutical Inc., Astellas Pharma Inc., Mylan N.V., Valeant Pharmaceutical Inc., Galderma SA, Dow Inc., Connetics Corporation, Fujisawa Pharmaceutical Company Ltd., AbbVie Inc., F. Hoffmann-La Roche Ltd., Valeant Pharmaceuticals International Inc,, GlaxoSmithKline plc, Medimmune Inc., Bausch Health Co. Inc., Nestlé Skin Health India Pvt. Ltd., Aqua Pharmaceuticals Pvt. Ltd., C.H. Boehringer Sohn AG & Co. KG, Biofrontera AG, Zydus Lifesciences Limited
Which key trends are expected to influence the dermatitis market in the coming years?
The dermatitis market has witnessed a trend of increasing mergers and acquisitions (M&As), done with the purpose of business expansion and increasing visibility. M&As are playing a significant role in today’s world and are assumed to expand this market in the years to come. The vendors in this industry are focusing on collaboration and partnerships to expand their portfolios and improve their market presence. Companies are also strategically making M&As to reduce competition and increase the scalability of their businesses. For instance, in March 2022, Pfizer Inc., a US-based pharmaceutical manufacturing company, acquired Arena Pharmaceuticals, Inc. for an undisclosed amount. With this acquisition, Pfizer aims to strengthen its portfolio of therapeutic candidates in various stages of development within the fields of gastroenterology, dermatology, and cardiology. Arena Pharmaceuticals, Inc. is a US-based clinical-stage company developing treatments for dermatology diseases such as atopic dermatitis (AD).
Which regional trends are influencing the dermatitis market, and which area dominates the industry?
North America was the largest region in the dermatitis market in 2023. Middle East is expected to be the fastest-growing region in the dermatitis market report during the forecast period. The regions covered in the dermatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Does The Dermatitis Market Report 2025 Offer?
The dermatitis market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Dermatitis refers to the inhibitors that treat skin inflammation, which is characterized by itchy rashes on swollen and reddish skin in the outer layer of the body. It is a general term that describes a common skin irritation.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2413
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
